IL-17 in systemic lupus erythematosus

  • Qian W
  • La Cava A
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and the formation of immune complexes that can damage multiple tissues, organs and systems. IL-17 is a proinflammatory cytokine that plays an important role in several autoimmune diseases including SLE. The expression of IL-17 is elevated in both SLE patients and in lupus-prone mice, and it is positively correlated with disease activity. IL-17 also appears to participate in the development of several SLE complications. In this article, we provide an overview and an update of the role of IL-17 in SLE., (C) 2012 Future Science Ltd.

Cite

CITATION STYLE

APA

Qian, W., & La Cava, A. (2012). IL-17 in systemic lupus erythematosus. Clinical Investigation, 2(4), 417–421. https://doi.org/10.4155/cli.12.21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free